NRC

Business Context and Reporting Period

Company: National Research Corporation (NRC Health)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: NRC Health provides survey-based performance measurement, analysis, tracking, improvement services, and governance education to the healthcare industry in the U.S. and Canada. The company utilizes direct mail, telephone surveys, and other methodologies to help healthcare organizations comply with regulatory standards and improve business practices.

Key Financial Metrics

Note: Working capital deficiency calculated as Current Assets ($13,583,056) minus Current Liabilities ($22,178,828). Total Debt calculated as Current portion of note payable ($6,265,889) plus Note payable net of current portion ($351,248).

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 10.2% year-over-year, driven by growth in higher-margin subscription-based services and expanded scope of work from existing clients.
• Profitability: Operating income increased 21.0% to $3.3 million. Operating margin improved to 24.5% from 22.4% in the prior year.
• Expense Management: Direct expenses rose 8.8% but decreased as a percentage of revenue (44.0% vs. 44.6%). Selling, general, and administrative (SG&A) expenses increased 4.7% but decreased as a percentage of revenue (26.5% vs. 27.9%) due to the mix of higher-margin products.
• Cash Flow: Net cash provided by operating activities decreased significantly to $2.1 million from $4.4 million in the prior year, primarily due to a larger increase in trade accounts receivable ($3.2 million outflow vs. $2.2 million outflow in 2007).
• Debt Structure: The company refinanced a term note in February 2008 and increased the revolving credit facility limit to $6.5 million. As of March 31, 2008, the revolving note balance was $5.2 million.

Guidance, Outlook, and Risks

• Expense Outlook: Management expects direct expenses to remain at the higher end of its 43%-45% model for the remainder of 2008. SG&A expenses are expected to remain slightly outside the 23%-25% model, similar to Q1 levels. Depreciation and amortization are expected to remain in the middle of the 4.5%-6.0% model.
• Capital Expenditures: The company budgeted approximately $1.9 million for capital expenditures in 2008, primarily for hardware, software, and production equipment.
• Debt Maturity: The revolving credit note matures on July 31, 2008. Management intends to renew the note and expects cash flows from operations to be sufficient to repay the remaining borrowings before expiration. However, there is no assurance of renewal or that cash flows will occur as forecasted.
• Stock Repurchases: The company repurchased $6.6 million of treasury stock in Q1 2008. As of March 31, 2008, 425,138 shares remained available for purchase under the authorized program.
• Risk Factors: No material changes to risk factors were reported since the 2007 Annual Report. Key risks include the ability to renew credit facilities and reliance on cash flows to service debt.

Investor Verification Checklist

• Debt Renewal: Verify the status of the revolving credit note renewal scheduled for July 31, 2008, given the $5.2 million outstanding balance.
• Working Capital: Monitor the working capital deficiency of $8.6 million and the company's ability to manage liquidity while funding stock repurchases.
• Accounts Receivable: Review the significant increase in trade accounts receivable ($3.2 million increase in the quarter) and its impact on operating cash flow.
• Revenue Mix: Confirm the sustainability of the shift toward higher-margin subscription services driving the improved operating margin.
• Share Count: Track the impact of the active stock repurchase program on shares outstanding and future earnings per share.